3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Breast Cancer -

Mistrust makes some women delay breast exam

Cancer • • Breast CancerFeb 05, 09

A lack of trust in the health care system leads many women from minority groups to delay breast cancer screening, according to results of a study reported Thursday at the American Association for Cancer Research conference on the Science of Health Care Disparities in Carefree, Arizona.

“Our medical systems, in general, have some work to do to build better-trusted relationships with racial and ethnic women,” Dr. Karen Patricia Williams from Michigan State University in East Lansing told the conference.

Williams and colleagues analyzed medical mistrust and breast cancer screening behaviors among 116 African American, 113 Latina, and 112 Arab American women who were eligible for screening; their average age was 46 years.

Ninety-four percent of African American women had health insurance, as did 45 percent and 43 percent, respectively, of Latina and Arab American women.

The researchers found that women who had not received appropriately timed clinical breast exams had higher levels of medical mistrust than those who had received timely breast cancer screening.

“African-American women had the highest levels of mistrust, but most of the women studied in the other groups were also clustered around ‘strongly agreeing’ or ‘agreeing’ with the statement that caution was recommended in dealing with health care organizations,” Williams noted.

Nearly half of the women (49 percent) agreed with the statement, “patients have sometimes been deceived or misled by health care organizations” and 39 percent of African American women did not trust health care organizations to keep their information private. This notion was echoed by 15 percent of Latina women and 9 percent of Arab American women.

This lack of trust led to a lower screening rate. Among the women who had never received a clinical breast exam, 44 percent agreed that “health care organizations have sometimes done harmful experiments without our knowledge.”

In addition, 64 percent of women who had not received a clinical breast exam in the past 12 months agreed with the statement: “Sometimes I wonder if health care organizations really know what they are doing.” Among women who had received a clinical breast exam in the last year, 47 percent agreed with this statement.

“While insurance obviously plays a large role in screening, we can’t ignore that medical mistrust also plays a role,” Williams concluded.


By Megan Rauscher
NEW YORK (Reuters Health)



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site